CONCORDBIO:NSE
Concord Biotech Ltd
₹1.354,80
arrow_downward
-1,98%(-27,30) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹1.390,80
High
₹1.394,90
Low
₹1.350,00
Mkt. cap
141,73 ຕື້
Avg. vol.
139,50 ພັນ
Volume
35,98 ພັນ
Dividend
0,56%
Quarterly dividend
₹1,89
Ex-dividend date
24 ກ.ລ. 2026
P/E ratio
51,50
52-wk high
₹1.615,00
52-wk low
₹987,00
EPS
₹26,31
No. of employees
2 ພັນ
Open
₹1.390,80
High
₹1.394,90
Low
₹1.350,00
Mkt. cap
141,73 ຕື້
Avg. vol.
139,50 ພັນ
Volume
35,98 ພັນ
Dividend
0,56%
Quarterly dividend
₹1,89
Ex-dividend date
24 ກ.ລ. 2026
P/E ratio
51,50
52-wk high
₹1.615,00
52-wk low
₹987,00
EPS
₹26,31
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investor's Business Daily
·
33 ນາທີກ່ອນ
Dow Jones Futures: Techs Slide On Anthropic Valuation Doubts; Tesla Roadster On Tap
Simply Wall Street
·
1 ນາທີກ່ອນ
Does VeriSign Stock Face A Trust Test After Ending Third Level Name Domains
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Grayscale Says Bitcoin’s Volatility Falls to 43%, Now Within S&P 500 Range
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd